• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Green Mountain Power

Green Mountain Power

  1. ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia

    ERYTECH Completes Patient Enrollment in Phase 2b Trial for eryaspase (GRASPA®) in Acute Myeloid Leukemia

  2. Bone Therapeutics Notice of Half Year 2016 Results

    Bone Therapeutics Notice of Half Year 2016 Results

  3. Elekta Expands Its Presence in North Africa Through Joint Venture

    Elekta Expands Its Presence in North Africa Through Joint Venture

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.